243 related articles for article (PubMed ID: 28413861)
21. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats.
Fathy M; Okabe M; Saad Eldien HM; Yoshida T
Molecules; 2020 Jan; 25(2):. PubMed ID: 31952158
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.
Abdel Aziz MT; Atta HM; Mahfouz S; Fouad HH; Roshdy NK; Ahmed HH; Rashed LA; Sabry D; Hassouna AA; Hasan NM
Clin Biochem; 2007 Aug; 40(12):893-9. PubMed ID: 17543295
[TBL] [Abstract][Full Text] [Related]
23. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis.
Okura H; Soeda M; Morita M; Fujita M; Naba K; Ito C; Ichinose A; Matsuyama A
Biochem Biophys Res Commun; 2015 Jan; 456(4):860-5. PubMed ID: 25490388
[TBL] [Abstract][Full Text] [Related]
26. Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis.
Abdelgwad M; Ewaiss M; Sabry D; Khalifa WA; Altaib ZM; Alhelf M
Arch Physiol Biochem; 2022 Aug; 128(4):1071-1080. PubMed ID: 32374186
[TBL] [Abstract][Full Text] [Related]
27. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl
Baig MT; Ghufran H; Mehmood A; Azam M; Humayun S; Riazuddin S
Biochem Pharmacol; 2021 Apr; 186():114480. PubMed ID: 33617844
[TBL] [Abstract][Full Text] [Related]
28. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl
Zhang Y; Li R; Rong W; Han M; Cui C; Feng Z; Sun X; Jin S
Cell Death Dis; 2018 Dec; 9(12):1186. PubMed ID: 30538216
[TBL] [Abstract][Full Text] [Related]
30. Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl
Elmahdy NA; Sokar SS; Salem ML; Sarhan NI; Abou-Elela SH
Biomed Pharmacother; 2017 May; 89():1378-1386. PubMed ID: 28320105
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis.
Khalil MR; El-Demerdash RS; Elminshawy HH; Mehanna ET; Mesbah NM; Abo-Elmatty DM
Biomed J; 2021 Oct; 44(5):598-610. PubMed ID: 32389821
[TBL] [Abstract][Full Text] [Related]
32. Melatonin Improves the Resistance of Oxidative Stress-Induced Cellular Senescence in Osteoporotic Bone Marrow Mesenchymal Stem Cells.
Chen W; Lv N; Liu H; Gu C; Zhou X; Qin W; Chen AC; Chen L; Yang H; Chen X; Liu T; He F
Oxid Med Cell Longev; 2022; 2022():7420726. PubMed ID: 35087617
[TBL] [Abstract][Full Text] [Related]
33. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
34. Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats.
Du C; Jiang M; Wei X; Qin J; Xu H; Wang Y; Zhang Y; Zhou D; Xue H; Zheng S; Zeng W
Int J Mol Med; 2018 Jun; 41(6):3175-3184. PubMed ID: 29512750
[TBL] [Abstract][Full Text] [Related]
35. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
[TBL] [Abstract][Full Text] [Related]
36. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow or adipose tissue mesenchymal stem cells: Comparison of the therapeutic potentials in mice model of acute liver failure.
Zare H; Jamshidi S; Dehghan MM; Saheli M; Piryaei A
J Cell Biochem; 2018 Jul; 119(7):5834-5842. PubMed ID: 29575235
[TBL] [Abstract][Full Text] [Related]
39. Comparative study on the effect of low intensity laser and growth factors on stem cells used in experimentally-induced liver fibrosis in mice.
Naguib E; Kamel A; Fekry O; Abdelfattah G
Arab J Gastroenterol; 2017 Jun; 18(2):87-97. PubMed ID: 28625529
[TBL] [Abstract][Full Text] [Related]
40. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
